Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill(Neurosciences Institute), Anthony H.V. Schapira(National Hospital for Neurology and Neurosurgery), Jonathan M. Cooper(University of Glasgow), Kai‐Yin Chau(National Hospital for Neurology and Neurosurgery), Andrey Y. Abramov(National Hospital for Neurology and Neurosurgery), Derralynn Hughes(Royal Free London NHS Foundation Trust), Chengguo Shen(University of Nottingham), Matthew E. Gegg(National Hospital for Neurology and Neurosurgery), Joana Magalhães(Neurosciences Institute), Atul Mehta(University College London)
Cited by 321
Related Papers
The emerging role of Nrf2 in mitochondrial function
|Free Radical Biology and Medicine|2015|958
Mechanism of Oxidative Stress in Neurodegeneration
|Oxidative Medicine and Cellular Longevity|2012|940
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
|Human Molecular Genetics|2010|896
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Role of mitochondrial <scp>ROS</scp> in the brain: from physiology to neurodegeneration
|FEBS Letters|2018|744